Omega 3-Atorvastatin
B-2111-720-004
Approved small_molecule active
Quick answer
Omega 3-Atorvastatin for Dyslipidemias is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Dyslipidemias
- Phase
- Approved
- Modality
- small_molecule
- Status
- active